Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

NCT06169371 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Abemaciclib
DRUG: Abemaciclib
DRUG: Abemaciclib

Sponsor

University of Illinois at Chicago